The faces and names behind the year's best pharmaceutical advertising.
An App for That
Cadient Interactive
BRAND Symbicort CLIENT AstraZeneca
The key to surviving on the Web is to create an environment that users feel comfortable visiting over and over again. With the site "My Measures for Success," Cadient Interactive has created a fully customizable home page in the style of MyYahoo.com—but designed for the asthma and COPD communities. The site currently has over 100,000 registered users, making it one of the most popular adherence programs on the market.
FROM LEFT: Jill de la Fuente, media designer, Bob Holloway, VP/group account director, Marisa McGettigan, account manager, Beth Hartzell, creative director, (SEATED) Kathy Fitzpatrick, senior project manager (PHOTO BY SCOTT NIBAUER)
According to Cadient, AstraZeneca was against building the typical customer relationship management program—blasting canned e-mails to patients was not the answer. Rather, Cadient's program is designed using online applications that reside on the patient's personal Web page. And the best part is that the tools are really useful. Viewers can choose to see pollen counts, air quality alerts, and doctor reminders all on one page, which also provides a rewards program encouraging patients to continue with their treatment regiment.
"You have to provide value to the user to make them want to be involved," says Bob Holloway, VP, group account director. "On the other hand, the company has to see a value in [the technology] —something that actually helps people stay on their medication, or get to find out more information about the treatment."
Trends in Continuing Medical Education
April 12th 2024Elliott Yoo, Senior Media Strategist at epocrates, takes a closer look at the trends in CME consumption and what the future of medical education will be – from the priorities for physicians as they juggle learning with patient care, to what type of activities resonate most with prescribers.
Transforming Cancer Care: Data, AI, and Patient-Centered Care
July 20th 2023Join us as Mohit Manrao, SVP and head of US oncology at AstraZeneca, shares his patient-centered approach to transforming cancer care, bridging the gap between innovative science and tangible patient outcomes across all populations on a global scale.